{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:05:30Z","timestamp":1779858330586,"version":"3.53.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cpcardiol.2026.103355","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:04:41Z","timestamp":1776701081000},"page":"103355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac dysfunction in HIV: Etiology, pathophysiology, and future directions"],"prefix":"10.1016","volume":"51","author":[{"given":"Youssef A.","family":"Elnabawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Marashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman N.","family":"Aiad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Zaghlol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K.","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2026.103355_bib0001","article-title":"Diagnosis of HIV infection in the united states and dependent areas, 2017","volume":"29","year":"2017"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001418","article-title":"Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies","volume":"10","author":"Johnson","year":"2013","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0003","first-page":"59","article-title":"Cardiac disease associated with human immunodeficiency virus infection","volume":"35","author":"Bloomfield","year":"2017","journal-title":"Cardiol Clin"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103355_bib0004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.cpcardiol.2026.103355_bib0005","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/CIRCULATIONAHA.117.028975","article-title":"Cardiovascular risk prediction functions underestimate risk in HIV infection","volume":"137","author":"Triant","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0006","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the veterans aging cohort study","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0007","first-page":"531","article-title":"HIV infection and risk of heart failure: a meta-analysis and systematic review","volume":"69","author":"Li","year":"2022","journal-title":"Acta Biochim Pol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0008","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jchf.2018.10.006","article-title":"Cardiac dysfunction among people living with HIV: a systematic review and meta-analysis","volume":"7","author":"Erqou","year":"2019","journal-title":"JACC Heart fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0009","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/QAI.0000000000002629","article-title":"Human Immunodeficiency Virus infection and incident heart failure: a meta-analysis of prospective studies","volume":"87","author":"Chen","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103355_bib0010","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/QAD.0000000000004182","article-title":"Multicenter study of heart failure phenotypes and physician-adjudicated causes in people with HIV","volume":"39","year":"2025","journal-title":"AIDS"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0011","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1056\/NEJMoa1914279","article-title":"Sudden cardiac death and myocardial fibrosis, determined by autopsy, in persons with HIV","volume":"384","author":"Tseng","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.csbj.2015.02.001","article-title":"Possible biomarkers for the early detection of HIV-associated heart diseases: a proteomics and bioinformatics prediction","volume":"13","author":"Rasheed","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jinf.2008.02.006","article-title":"Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy","volume":"57","author":"Calza","year":"2008","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004987","article-title":"Changes in cardiovascular disease risk factors with immediate versus deferred antiretroviral therapy initiation among HIV-positive participants in the START (strategic timing of antiretroviral treatment) trial","volume":"6","author":"Baker","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0016","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cardfail.2018.02.001","article-title":"Diastolic dysfunction in individuals with human immunodeficiency virus infection: literature review, rationale and design of the characterizing heart function on antiretroviral therapy (CHART) study","volume":"24","author":"Butler","year":"2018","journal-title":"J Card Fail"},{"issue":"9903","key":"10.1016\/j.cpcardiol.2026.103355_bib0018","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103355_bib0019","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.113.001719","article-title":"Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients","volume":"128","author":"Holloway","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0020","first-page":"299","article-title":"Cardiomyopathy and heart failure in patients with HIV infection","volume":"35","author":"Savvoulidis","year":"2019","journal-title":"Can J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.cpcardiol.2026.103355_bib0021","article-title":"Immunopathogenesis of HIV-related heart muscle disease: current perspectives","volume":"17","author":"Currie","year":"2003","journal-title":"Aids"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0022","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0735-1097(94)90865-6","article-title":"Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus","volume":"24","author":"Herskowitz","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103355_bib0023","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103355_bib0024","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/QAD.0000000000001109","article-title":"Inflammation, immune activation, and cardiovascular disease in HIV","volume":"30","author":"Nou","year":"2016","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/COH.0000000000000228","article-title":"Immune activation during acute HIV infection and the impact of early antiretroviral therapy","volume":"11","author":"Krebs","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/157016211795569078","article-title":"Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on non-specific immune activation","volume":"9","author":"Bartovska","year":"2011","journal-title":"Curr HIV Res"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0027","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/QAI.0b013e318285cd33","article-title":"Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation","volume":"62","author":"Vinikoor","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065182","article-title":"Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy","volume":"8","author":"Ronsholt","year":"2013","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0029","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QAI.0b013e318289bced","article-title":"Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long-term treatment with combination antiretroviral therapy","volume":"63","author":"Pedersen","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103355_bib0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/cmi.2017.109","article-title":"Monocyte activation and cardiovascular disease in HIV infection","volume":"14","author":"Liang","year":"2017","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007849","article-title":"Role of monocytes in heart failure and atrial fibrillation","volume":"7","author":"Shahid","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.cpcardiol.2026.103355_bib0032","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574","article-title":"Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research","volume":"129","author":"Remick","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0033","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/QAD.0b013e3282f57f61","article-title":"Antigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFalpha","volume":"22","author":"Yearley","year":"2008","journal-title":"Aids"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000844","article-title":"Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation","volume":"3","author":"Nordell","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.cpcardiol.2026.103355_bib0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jchf.2018.07.009","article-title":"Adiposity and incident heart failure and its subtypes: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Rao","year":"2018","journal-title":"JACC Heart fail"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0036","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/QAD.0000000000002060","article-title":"Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV","volume":"33","author":"Srinivasa","year":"2019","journal-title":"Aids"},{"issue":"16","key":"10.1016\/j.cpcardiol.2026.103355_bib0037","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","article-title":"High-sensitive cardiac troponin T as an early biochemical signature for clinical and subclinical heart failure: MESA (multi-ethnic study of atherosclerosis)","volume":"135","author":"Seliger","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103355_bib0038","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1210\/jc.2015-1461","article-title":"RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients","volume":"100","author":"Srinivasa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004430","article-title":"HIV-1-related cardiovascular disease is associated with chronic inflammation, frequent pericardial effusions, and probable myocardial edema","volume":"9","author":"Ntusi","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103355_bib0040","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/infdis\/jiv274","article-title":"Abnormal myocardial function is related to myocardial steatosis and diffuse myocardial fibrosis in HIV-infected adults","volume":"212","author":"Thiara","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0041","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12968-015-0193-2","volume":"17","author":"Diaz-Zamudio","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7 Suppl","key":"10.1016\/j.cpcardiol.2026.103355_bib0042","doi-asserted-by":"crossref","first-page":"59B","DOI":"10.1016\/j.amjcard.2015.01.042","article-title":"Bayes-Genis A. Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography","volume":"115","author":"deFilippi","year":"2015","journal-title":"Am J Cardiol"},{"issue":"Issue Supplement_1","key":"10.1016\/j.cpcardiol.2026.103355_bib0043","first-page":"S63","article-title":"Myocardial steatosis among antiretroviral therapy\u2013Treated people with Human immunodeficiency virus participating in the REPRIEVE trial","volume":"222","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0044","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8196560","article-title":"The causes of HIV-associated cardiomyopathy: a tale of two worlds","volume":"2016","author":"Lumsden","year":"2016","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0045","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.105.584532","article-title":"Myocarditis: current trends in diagnosis and treatment","volume":"113","author":"Magnani","year":"2006","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0046","first-page":"338","article-title":"Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction","volume":"30","author":"Izumiya","year":"2014","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0047","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2010.159277","article-title":"Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction","volume":"57","author":"Shah","year":"2011","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103355_bib0048","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103355_bib0049","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2004.07.023","article-title":"Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression","volume":"44","author":"Polyakova","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0050","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1161\/CIRCRESAHA.122.322459","article-title":"Platelet-derived microRNAs regulate cardiac remodeling after myocardial ischemia","volume":"132","author":"Sch\u00fctte","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0051","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/HYPERTENSIONAHA.117.09262","article-title":"P2y12 receptor promotes pressure overload-induced cardiac remodeling via platelet-driven inflammation in mice","volume":"70","author":"Wu","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0052","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0053","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12916-020-01801-9","article-title":"Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis","volume":"18","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.cpcardiol.2026.103355_bib0054","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5603\/CJ.a2019.0051","article-title":"Pretreatment with antiplatelet drugs improves the cardiac function after myocardial infarction without reperfusion in a mouse model","volume":"28","author":"Zhang","year":"2021","journal-title":"Cardiol J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/ATVBAHA.113.302191","article-title":"HIV, inflammation, and calcium in atherosclerosis","volume":"34","author":"Shrestha","year":"2014","journal-title":"Arter Thromb Vasc Biol"},{"issue":"25","key":"10.1016\/j.cpcardiol.2026.103355_bib0056","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.jacc.2017.05.012","article-title":"HIV-1-associated atherosclerosis: unraveling the missing link","volume":"69","author":"Kearns","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0057","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"Subramanian","year":"2012","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0058","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jamacardio.2016.0846","article-title":"Effects of antiretroviral therapy on immune function and arterial inflammation in treatment-naive patients with Human Immunodeficiency virus infection","volume":"1","author":"Zanni","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0059","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.CIR.0000048123.22359.A0","article-title":"Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations","volume":"107","author":"Kawaguchi","year":"2003","journal-title":"Circulation"},{"issue":"8\u20139","key":"10.1016\/j.cpcardiol.2026.103355_bib0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.acvd.2017.03.001","article-title":"HIV infection and aortic stiffness","volume":"110","author":"Leite","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.cpcardiol.2026.103355_bib0061","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamacardio.2019.2589","article-title":"Association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by perivascular fat attenuation index","volume":"4","author":"Elnabawi","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103355_bib0062","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0063","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157340308784245775","article-title":"Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors","volume":"4","author":"Zeller","year":"2008","journal-title":"Curr Cardiol Rev"},{"issue":"19","key":"10.1016\/j.cpcardiol.2026.103355_bib0064","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/eurheartj\/ehs471","article-title":"Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era","volume":"34","author":"Cerrato","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0066","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.CIR.101.2.185","article-title":"Dilated cardiomyopathy associated with simian AIDS in nonhuman primates","volume":"101","author":"Shannon","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0067","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02630896","article-title":"Establishment of a human fetal cardiac myocyte cell line","volume":"27","author":"Wang","year":"1991","journal-title":"In Vitro Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0068","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00059.2003","article-title":"38 MAP kinase-mediated negative inotropic effect of HIV gp120 on cardiac myocytes","volume":"286","author":"Kan","year":"2004","journal-title":"Am j physiol Cell physiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0069","doi-asserted-by":"crossref","first-page":"H3138","DOI":"10.1152\/ajpheart.2000.279.6.H3138","article-title":"HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappaB activation","volume":"279","author":"Kan","year":"2000","journal-title":"Am j physiol Heart circ physiol"},{"issue":"Suppl O","key":"10.1016\/j.cpcardiol.2026.103355_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/eurheartj\/16.suppl_O.50","article-title":"Dilated heart muscle disease associated with HIV infection","volume":"16","author":"Herskowitz","year":"1995","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0071","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00059-005-2728-z","article-title":"HIV-associated cardiomyopathy etiopathogenesis and clinical aspects","volume":"30","author":"Barbaro","year":"2005","journal-title":"Herz"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0072","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/CT:4:2:097","article-title":"HIV-1 induces cardiomyopathyby cardiomyocyte invasion and gp120, tat, and cytokine apoptotic signaling","volume":"4","author":"Fiala","year":"2004","journal-title":"Cardiovasc Toxicol"},{"issue":"22","key":"10.1016\/j.cpcardiol.2026.103355_bib0073","doi-asserted-by":"crossref","first-page":"14386","DOI":"10.1073\/pnas.212327899","article-title":"Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways","volume":"99","author":"Twu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0074","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00126334-200107010-00018","article-title":"Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy","volume":"27","author":"Bijl","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"22","key":"10.1016\/j.cpcardiol.2026.103355_bib0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126315","article-title":"Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathies","volume":"4","author":"Brayson","year":"2019","journal-title":"JCI insight"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0076","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0000000000003786","article-title":"Initial antiretroviral therapy regimen and risk of heart failure","volume":"38","author":"Silverberg","year":"2024","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0077","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2018.04.083","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV and heart failure","volume":"72","author":"Alvi","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0078","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2217\/clp.11.25","article-title":"Management of dyslipidemia in HIV-infected patients","volume":"6","author":"Malvestutto","year":"2011","journal-title":"Clin Lipidol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2026.103355_bib0079","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.amjcard.2013.05.036","article-title":"Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging","volume":"112","author":"Nelson","year":"2013","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103355_bib0080","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jcmg.2014.04.024","article-title":"Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy","volume":"7","author":"Nelson","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0081","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American heart association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0082","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0083","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/QAI.0b013e3181c6c4b7","article-title":"The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men","volume":"53","author":"Freiberg","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.cpcardiol.2026.103355_bib0084","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1089\/aid.2014.0069","article-title":"Taming HIV-related inflammation with physical activity: a matter of timing","volume":"30","author":"d'Ettorre","year":"2014","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"10.1016\/j.cpcardiol.2026.103355_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007107","article-title":"Disparities in the quality of cardiovascular care between HIV-infected versus HIV-uninfected adults in the United States: a cross-sectional study","volume":"6","author":"Ladapo","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.cpcardiol.2026.103355_bib0086","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1189\/JLB.2A0414-192R","article-title":"Renin modulates HIV replication in T cells","volume":"96","author":"Chandel","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2026.103355_bib0087","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3851\/IMP1809","article-title":"Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients","volume":"16","author":"Vecchiet","year":"2011","journal-title":"Antivir Ther"},{"issue":"14","key":"10.1016\/j.cpcardiol.2026.103355_bib0088","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1097\/QAD.0000000000001186","article-title":"Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals","volume":"30","author":"Fitch","year":"2016","journal-title":"Aids"},{"issue":"8","key":"10.1016\/j.cpcardiol.2026.103355_bib0089","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jchf.2015.03.007","article-title":"Novel biomarkers of cardiac stress, cardiovascular dysfunction, and outcomes in HIV-infected individuals","volume":"3","author":"Secemsky","year":"2015","journal-title":"JACC Heart fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2026.103355_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-022-00901-0","article-title":"Evolution of myocardial oedema and fibrosis in HIV infected persons after the initiation of antiretroviral therapy: a prospective cardiovascular magnetic resonance study","volume":"24","author":"Robbertse","year":"2022","journal-title":"J Cardiovasc Magn Reson"},{"issue":"18","key":"10.1016\/j.cpcardiol.2026.103355_bib0091","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1097\/QAD.0000000000002031","article-title":"High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy","volume":"32","author":"Majonga","year":"2018","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0092","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4103\/0971-5916.92634","article-title":"Human immunodeficiency virus & cardiovascular risk","volume":"134","author":"Barbaro","year":"2011","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.cpcardiol.2026.103355_bib0093","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/jinf.2000.0672","article-title":"Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement","volume":"40","author":"Pugliese","year":"2000","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.cpcardiol.2026.103355_bib0094","first-page":"176","article-title":"Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study","volume":"1","author":"Reinsch","year":"2011","journal-title":"Am J Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.cpcardiol.2026.103355_bib0095","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/jc.2018-00330","article-title":"Randomized, placebo-controlled trial to evaluate effects of eplerenone on metabolic and inflammatory indices in HIV","volume":"103","author":"Srinivasa","year":"2018","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280626000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:46:24Z","timestamp":1779857184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280626000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0146280626000976"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103355","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac dysfunction in HIV: Etiology, pathophysiology, and future directions","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2026.103355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103355"}}